Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles. | Front Immunol | 2023 | 36798121 | PubTator, text mining | PubMed |
| Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy. | Mol Cancer | 2023 | 36797756 | PubTator, text mining | PubMed |
| Lysosomal lipid peroxidation regulates tumor immunity. | J Clin Invest | 2023 | 36795483 | PubTator, text mining | PubMed |
| Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems. | Cancer Med | 2023 | 36794651 | PubTator, text mining | PubMed |
| Challenges and future of HER2-positive gastric cancer therapy. | Front Oncol | 2023 | 36793592 | PubTator, text mining | PubMed |
| Effect of membrane depolarization against Aspergillus niger GM31 resistant by ultra nanoclusters characterized by Ag2+ and Ag3+ oxidation state. | Sci Rep | 2023 | 36792916 | PubTator, text mining | PubMed |
| Advances in NK cell therapy for brain tumors. | NPJ Precis Oncol | 2023 | 36792722 | PubTator, text mining | PubMed |
| TCR-engineered T cell therapy in solid tumors: State of the art and perspectives. | Sci Adv | 2023 | 36791198 | PubTator, text mining | PubMed |
| CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance. | Cancer Cell | 2023 | 36787696 | PubTator, text mining | PubMed |
| Comparison of the efficacy of second and third generation lentiviral vector transduced CAR CD19 T cells for use in the treatment of acute lymphoblastic leukemia both in vitro and in vivo models. | PLoS One | 2023 | 36780428 | PubTator, text mining | PubMed |
| T lymphocyte cell: A pivotal player in lung cancer. | Front Immunol | 2023 | 36776832 | PubTator, text mining | PubMed |
| CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm. | Int J Mol Sci | 2023 | 36769040 | PubTator, text mining | PubMed |
| Comparison between Sickle Cell Disease Patients and Healthy Donors: Untargeted Lipidomic Study of Erythrocytes. | Int J Mol Sci | 2023 | 36768849 | PubTator, text mining | PubMed |
| Cell Immunotherapy against Melanoma: Clinical Trials Review. | Int J Mol Sci | 2023 | 36768737 | PubTator, text mining | PubMed |
| CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy. | Int J Mol Sci | 2023 | 36768665 | PubTator, text mining | PubMed |
| A Novel Role of the Two-Component System Response Regulator UvrY in Enterohemorrhagic Escherichia coli O157:H7 Pathogenicity Regulation. | Int J Mol Sci | 2023 | 36768620 | PubTator, text mining | PubMed |
| Natural Killer Cell-Based Immunotherapy against Glioblastoma. | Int J Mol Sci | 2023 | 36768432 | PubTator, text mining | PubMed |
| Head and Neck Cancer Immunotherapy: Molecular Biological Aspects of Preclinical and Clinical Research. | Cancers (Basel) | 2023 | 36765809 | PubTator, text mining | PubMed |
| CAR-T: What Is Next? | Cancers (Basel) | 2023 | 36765623 | PubTator, text mining | PubMed |
| The genetic basis of multiple system atrophy. | J Transl Med | 2023 | 36765380 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=40